Dear Mr. Pfreundschuh:Immunomedics Inc • March 7th, 2014 • In vitro & in vivo diagnostic substances • New Jersey
We are pleased to inform you that the Compensation Committee of the Company’s Board of Directors has approved a special change in control severance benefit program for you. The purpose of this letter agreement is to set forth the terms and conditions of your change in control severance benefits and to explain certain limitations that may govern their overall value or payment date.
